BAROnova, Inc.

The US Food and Drug Administration on 16 April approved a PMA for BAROnova Inc. ’s TransPyloric Shuttle (TPS) and its delivery system to treat obesity. TPS is an endoscopically delivered silicone de

The highly competitive global market for minimally invasive weight loss (bariatric) devices is predicted to rise from $137m in 2016 to $290m by 2021, a CAGR of 16%. This is driven in large part by the

Company Changes BRENNEMAN , Ryan R. To: EyeGate Pharmaceuticals Inc. , CFO (April) From: CYS Investments Inc., SVP, Chief Accounting Officer Phone: 781-788-9043 CHEN , Jiayu, PhD To: Gyneso

New At The Helm Company Changes ANDRE , Patrick, PhD To: Pliant Therapeutics Inc. , VP, Biology (April) From: Merck Sharp & Dohme Corp., Principal Scientist Phone: 650-481-6708 BRENNEMAN , Rya